Advertisement

Advertisement

GOSS Stock Latest News

Gossamer Bio Secures Major Seralutinib Regulatory Financing Deal

Company AnnouncementsGossamer Bio Secures Major Seralutinib Regulatory Financing Deal

Gossamer Bio announces upt to $250M structured private placement

PremiumThe Fly

Gossamer Bio announces upt to $250M structured private placement

2d ago

Gossamer Bio reports Q2 EPS (8c), consensus (12c)

PremiumThe Fly

Gossamer Bio reports Q2 EPS (8c), consensus (12c)

7d ago

Gossamer Bio price target lowered to $4 from $15 at Piper Sandler

PremiumThe Fly

Gossamer Bio price target lowered to $4 from $15 at Piper Sandler

7d ago

GOSS Earnings this Week: How Will it Perform?

PremiumPre-Earnings

GOSS Earnings this Week: How Will it Perform?

14d ago

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

PremiumWeekend UpdatesOTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

22d ago

Gossamer Bio upgraded to Outperform from Market Perform at Leerink

The Fly

Gossamer Bio upgraded to Outperform from Market Perform at Leerink

27d ago

Gossamer Bio Reclaims Seralutinib Rights and Control

Company Announcements

Gossamer Bio Reclaims Seralutinib Rights and Control

27d ago

Morning Movers: Ensign Group surges following second quarter results

PremiumThe Fly

Morning Movers: Ensign Group surges following second quarter results

27d ago

Gossamer announces FDA regulatory update, reacquisition of Seralutinib rights

PremiumThe Fly

Gossamer announces FDA regulatory update, reacquisition of Seralutinib rights

27d ago

Gossamer Bio Sets Conversion Terms for Convertible Notes

PremiumCompany Announcements

Gossamer Bio Sets Conversion Terms for Convertible Notes

2M ago

Gossamer Bio announces determination of conversion rate for senior secured notes

PremiumThe Fly

Gossamer Bio announces determination of conversion rate for senior secured notes

2M ago

Gossamer Bio price target lowered to $2 from $5 at H.C. Wainwright

PremiumThe FlyGossamer Bio price target lowered to $2 from $5 at H.C. Wainwright

2M ago

Gossamer Bio Announces Final Convertible Notes Exchange Results

Company Announcements

Gossamer Bio Announces Final Convertible Notes Exchange Results

2M ago

Gossamer Bio announces final tender results

The Fly

Gossamer Bio announces final tender results

2M ago

Vanguard Total Stock Market (VTI) ETF Daily Update — June 16, 2026

PremiumMarket News

Vanguard Total Stock Market (VTI) ETF Daily Update — June 16, 2026

2M ago

Gossamer Bio shareholders reaffirm board and governance structure

PremiumCompany Announcements

Gossamer Bio shareholders reaffirm board and governance structure

3M ago

Gossamer Bio Restructures Capital Through Convertible Notes Exchange

PremiumCompany Announcements

Gossamer Bio Restructures Capital Through Convertible Notes Exchange

3M ago

Gossamer Bio announces early tender results, early settlement of solicitation

PremiumThe Fly

Gossamer Bio announces early tender results, early settlement of solicitation

3M ago

Gossamer Bio announces extension of early tender date for exchange offer

PremiumThe FlyGossamer Bio announces extension of early tender date for exchange offer

3M ago

Gossamer Bio Extends Early Deadline in Note Exchange

Company Announcements

Gossamer Bio Extends Early Deadline in Note Exchange

3M ago

Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/29/26?

Market News

Why Is Vanguard Total Stock Market (VTI) ETF Rising Today, 5/29/26?

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >